Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
March 13, 2008
Alternatives for heart transplantation?
J Brügemann
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
August 27, 2013
Life is Movement (Aristotle, 4th century BC)
J Brügemann, H Gerds-Ploeger
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 20, 2015
Physical training in patients with chronic heart failure: An elaboration of the statements from the Committee on Cardiac Rehabilitation of the Netherlands Society of Cardiology and the Netherlands Heart Foundation and review of studies on physical training in chronic heart failure
P J Senden, A Mosterd, J Brügemann
Drugs & Aging
|
August 1, 1997
Pharmacological management of arrhythmias in the elderly
I C Van Gelder, J Brügemann, H J Crijns
Drugs
|
April 8, 1998
Current treatment recommendations in antiarrhythmic therapy
I C Van Gelder, J Brügemann, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
June 5, 2015
The diagnosis of left ventricular assist device thrombosis
H Z R Gerds, J Brügemann, M Rienstra, et al.
Nederlands Tijdschrift Voor Tandheelkunde
|
March 3, 2006
[Cardiological (pharmaco)therapy and dental practice]
J Brügemann, I C van Gelder, J van der Meer, et al.
British Heart Journal
|
August 1, 1994
Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay
J Brügemann, J van der Meer, V J Bom, et al.
Drugs & Aging
|
August 1, 1995
Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients?
J Brügemann, P A de Graeff, J van der Meer, et al.
The European Respiratory Journal
|
November 1, 1995
Thrombolytic therapy of right heart emboli-in-transit
G A Jessurun, J Brügemann, J P Hamer, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
March 13, 2008
Alternatives for heart transplantation?
J Brügemann
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
August 27, 2013
Life is Movement (Aristotle, 4th century BC)
J Brügemann, H Gerds-Ploeger
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
February 20, 2015
Physical training in patients with chronic heart failure: An elaboration of the statements from the Committee on Cardiac Rehabilitation of the Netherlands Society of Cardiology and the Netherlands Heart Foundation and review of studies on physical training in chronic heart failure
P J Senden, A Mosterd, J Brügemann
Drugs & Aging
|
August 1, 1997
Pharmacological management of arrhythmias in the elderly
I C Van Gelder, J Brügemann, H J Crijns
Drugs
|
April 8, 1998
Current treatment recommendations in antiarrhythmic therapy
I C Van Gelder, J Brügemann, H J Crijns
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
June 5, 2015
The diagnosis of left ventricular assist device thrombosis
H Z R Gerds, J Brügemann, M Rienstra, et al.
Nederlands Tijdschrift Voor Tandheelkunde
|
March 3, 2006
[Cardiological (pharmaco)therapy and dental practice]
J Brügemann, I C van Gelder, J van der Meer, et al.
British Heart Journal
|
August 1, 1994
Streptokinase antibodies are of clinical importance and they can be measured in half an hour by a simple enzyme-linked immunosorbent assay
J Brügemann, J van der Meer, V J Bom, et al.
Drugs & Aging
|
August 1, 1995
Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients?
J Brügemann, P A de Graeff, J van der Meer, et al.
The European Respiratory Journal
|
November 1, 1995
Thrombolytic therapy of right heart emboli-in-transit
G A Jessurun, J Brügemann, J P Hamer, et al.
Page
of 4